Fundraising Fox
Seraphina Therapeutics
Founded 2017 · 14 employees on LinkedIn · 2 known investors
Find your way into Seraphina Therapeutics
Sign up to see every warm intro you have to Seraphina Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Seraphina Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age. The company focuses on evidence-based nutritional science for consumer wellness.
Founders & leadership
Seraphina Therapeutics was founded in 2017 by Stephanie Venn-Watson.
SV
Stephanie Venn-WatsonCo-Founder, Co-CEOStephanie Venn-Watson is a veterinary epidemiologist who has held research and leadership positions at the National Marine Mammal Foundation, DARPA, the Centers for Disease Control and Prevention, and the World Health Organization. She is co-founder and co-CEO of Seraphina Therapeutics, which develops nutritional products based on metabolomics research, and co-founder of Epitracker, a life sciences research organization.
Investors · 2
Frequently asked questions
- What does Seraphina Therapeutics do?
- Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age. The company focuses on evidence-based nutritional science for consumer wellness.
- Who founded Seraphina Therapeutics?
- Seraphina Therapeutics was founded by Stephanie Venn-Watson in 2017.
- Who are Seraphina Therapeutics's investors?
- Seraphina Therapeutics's investors include 1315 Capital, BioBrit.